tomhilsen Thursday, 12/20/18 02:53:43 PM Re: None Post # of 4721 The market cap of this stock is 7 million usd. NSI 189 has potential to grow neurons in the hippocampus. It has been shown to be safe. Dr. Eva Feldman has shown success in demented mice with injected proprietary stem cells. I think that we are orphan drug status for Angelman’s Syndrome where there is a cognitive deficit in children. Is a chance at treating Alzheimer’s or TBI only worth 7 million usd or is CUR perhaps undervalued?